South Korea Pharmaceutical Market Outlook 2013South Korea Pharmaceutical Market Outlook 2013SummaryGBI Research’s ne...
1 Table Of Contents1 Table Of Contents 51.1 List Of Tables 71.2 List Of Figures 82 Introduction 93 South Korea Pharmaceuti...
5.2 Prescription Drugs 425.2.1 Patented Drugs 435.2.2 Generics 445.3 Biotechnology 456 South Korea Pharmaceutical Market O...
9.4.1 Coverage 669.4.2 Secondary Research 669.4.3 Primary Research 669.4.4 Expert Panel Validation 679.5 Contact Us 679.6 ...
Upcoming SlideShare
Loading in …5
×

South Korea Pharmaceutical Market 2013 Available on Researchmoz.us

469 views

Published on

GBI Research’s new report “South Korea Pharmaceutical Market Outlook 2013” provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market. The report also provides competitive benchmarking for the country’s leading pharmaceutical companies and analyzes the M&A (Mergers and Acquisitions) and strategic partnerships that shape its pharmaceutical industry. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Published in: Business, Travel
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
469
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

South Korea Pharmaceutical Market 2013 Available on Researchmoz.us

  1. 1. South Korea Pharmaceutical Market Outlook 2013South Korea Pharmaceutical Market Outlook 2013SummaryGBI Research’s new report “South Korea Pharmaceutical Market Outlook 2013”provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceuticalmarket. The report also provides competitive benchmarking for the country’s leading pharmaceuticalcompanies and analyzes the M&A (Mergers and Acquisitions) and strategic partnerships that shape itspharmaceutical industry. It is built using data and information sourced from proprietary databases, primaryand secondary research and in-house analysis by GBI Research’s team of industry experts.The South Korean pharmaceutical market is the 10th largest pharmaceutical market, globally. The industry ishighly fragmented, with almost all the domestic pharmaceutical companies having a strong portfolio ofgeneric products rather than expensive, branded drugs. For the entire pharmaceutical industry, an increase ininsurance coverage, an ageing population and favorable government initiatives are expected to drive futuregrowth in the pharmaceutical industry.Improved Intellectual Property Rights (IPR), changing demographics, and government support havecontributed towards making the South Korean pharmaceutical industry attractive for multinational companies.The South Korean government has signed Free Trade Agreements (FTA) with the US, Europe and India thatare aimed at improving the IPR framework in the country and making the pharmaceutical industry moreattractive for foreign investment. The immediate effects of the FTA may not be positive in all respects for thegenerics-dominated domestic pharmaceutical industry. However, it is ultimately expected to bolster the SouthKorean pharmaceutical industry by increasing transparency in government policies and enforcement, and pricecompetition in the private sector.ScopeThe macroeconomic environment of the pharmaceutical industry in South Korea, covering demographicanalysis, trends, drivers and barriers Important industry characteristics, including the regulatory authorities,drug pricing, spending, insurance and reimbursement Market analysis of segments such as prescriptionmedicines, biotechnology and over-the-counter medicines Competitive profiling of major domestic andinternational companies operating in the South Korea pharmaceutical market Analyses of the licensing,partnership and M&A deals that took place between 2007 and 2012Reasons to buyDevelop market-entry and market-expansion strategies by identifying the leading segments poised for stronggrowth Devise a more specifically-tailored country strategy through understanding the key drivers and barriersfor the pharmaceutical market Develop key strategic initiatives by understanding leading companies’key focus areas Accelerate and strengthen your market position by identifying key companies for M&As andstrategic partnershipstable Of ContentsSouth Korea Pharmaceutical Market Outlook 2013
  2. 2. 1 Table Of Contents1 Table Of Contents 51.1 List Of Tables 71.2 List Of Figures 82 Introduction 93 South Korea Pharmaceutical Market Outlook 2013 – Overview 103.1 Global Pharmaceutical Industry Landscape 103.2 Macroscopic View Of The South Korea Pharmaceutical Market 103.3 Trade Balance 123.3.1 Exports 133.3.2 Imports 163.4 Demographic Analysis 183.4.1 Population Size, Growth, And Structure 183.4.2 Crude Death Rate 193.4.3 Causes Of Death 203.4.4 Crude Birth Rate 223.4.5 Infant Mortality Rate 233.4.6 Life Expectancy At Birth 243.4.7 Comparison Of Healthcare Indicators 253.5 Driver And Barriers Of South Korean Pharmaceutical Industry 263.5.1 Drivers 263.5.2 Barriers 284 South Korea Pharmaceutical Market Outlook 2013 – Industry Characteristics 294.1 Regulatory Agencies 294.1.1 Korea Food And Drug Administration 294.1.2 National Institute Of Food And Drug Safety Evaluation 304.2 Drug Pricing Policy 314.3 Healthcare Expenditure In South Korea 324.4 Healthcare Infrastructure 374.5 Insurance And Reimbursement 384.5.1 National Health Insurance 384.5.2 Long-term Care Insurance 394.5.3 Medical Aid 405 South Korea Pharmaceutical Market Outlook 2013 – Market Analysis 415.1 Over-the-counter Drugs 41South Korea Pharmaceutical Market Outlook 2013
  3. 3. 5.2 Prescription Drugs 425.2.1 Patented Drugs 435.2.2 Generics 445.3 Biotechnology 456 South Korea Pharmaceutical Market Outlook 2013 – Key Trends 486.1 Rapid Consolidations In The Domestic Market 486.1.1 M&a Deals 486.1.2 Partnership Deals 506.1.3 Licensing Deals 516.2 Understanding Local Markets To Build R&d 526.3 Free Trade Agreements 536.3.1 Intellectual Property Rights Protection 546.3.2 Transparency In Healthcare Regulatory And Reimbursement Process 546.3.3 Unethical Business Practices 547 South Korea Pharmaceutical Market Outlook 2013 – Competitive Landscape 557.1 Key Foreign Companies 557.1.1 Glaxosmithkline 557.1.2 Sanofi 557.1.3 Pfizer 567.2 Key Domestic Companies 577.2.1 Dong-a 577.2.2 Green Cross 587.2.3 Hanmi 597.2.4 Jw Holdings Corporation (choongwae Holdings Co., Ltd.) 607.2.5 Yuhan Corporation 608 South Korea Pharmaceutical Market Outlook 2013 – The Way Forward 618.1 Outlook 618.2 Opportunities Ahead 618.2.1 Biosimilars 618.2.2 Stem Cell Research 619 South Korea Pharmaceutical Market Outlook 2013 – Appendix 639.1 Market Definitions 639.2 Abbreviations 639.3 Bibliography 649.4 Research Methodology 66South Korea Pharmaceutical Market Outlook 2013
  4. 4. 9.4.1 Coverage 669.4.2 Secondary Research 669.4.3 Primary Research 669.4.4 Expert Panel Validation 679.5 Contact Us 679.6 Disclaimer 67ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market researchreports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with ourhuge collection of market research reports. We provide our services to all sizes of organizations and across allindustry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well aspublishers and will assist you in making an informed decision by giving you unbiased and deep insights onwhich reports will satisfy your needs at the best price.Contact:M/s Sheela,90 State Street,Suite 700,Albany NY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usWebsite: http://www.researchmoz.us/South Korea Pharmaceutical Market Outlook 2013

×